Skip to main content

Table 1 Demographic status of subjects in the intervention and control groups at baseline (N = 86)

From: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Characteristics

Intervention N = 44

Control N = 42

p.value*

Sex

Male

27 (61.4%)

22 (52.4%)

0.400

Female

17 (38.6%)

20 (47.6%)

Underlying diseases

Diabetes

15 (34.1%)

13 (31.0%)

0.756

Cardiovascular disease

12 (27.3%)

14 (33.3%)

0.541

Hypertension

19 (43.2%)

20 (47.6%)

0.679

Renal disease

2 (4.5%)

0 (0%)

0.495

Liver disease

0 (0%)

0 (0%)

–

Others

1 (2.3%)

3 (7.1%)

0.355

Smoking

Non-smoker

27 (61.4%)

27 (64.3%)

0.699

Ex-smoker

9 (20.5%)

10 (23.8%)

Smoker

8 (18.2%)

5 (11.9%)

O2 saturation < 85

22 (52.4%)

20 (48.8%)

0.743

Age (year); mean ± standard deviation 

56.2 ± 17.5

61.3 ± 17.3

0.174

  1. * Chi square, Fisher’s Exact Test, T test